Navidea Biopharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Navidea Biopharmaceutical using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2021 | 2021-11-10 | $-0.08 | $-0.11 | 27.3 % |
Jun 2021 | 2021-08-11 | $-0.09 | $-0.08 | -12.5 % |
Mar 2021 | 2021-05-11 | $-0.12 | $-0.08 | -50.0 % |
Dec 2020 | 2021-03-24 | $-0.11 | $-0.12 | 8.33 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2020 | 2021-03-24 | $219.25K | $600.00K | -63.5 % |
Sep 2020 | 2020-11-12 | $268.39K | $150.00K | 78.9 % |
Jun 2020 | 2020-08-13 | $271.10K | $156.00K | 73.8 % |
Navidea Biopharmaceutical ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3.
Navidea Biopharmaceutical ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual EPS was $-0.02, which missed the estimate of $0.00.
Navidea Biopharmaceutical ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.